Zynerba Press Releases

7 Aug 17
Zynerba Pharmaceuticals Announces Top-Line Results from Phase 2 STAR 1 Trial of ZYN002 in Adult Epilepsy Patients with Focal Seizures

1 Aug 17
Zynerba Pharmaceuticals Reports Second Quarter 2017 Financial Results and Operational Highlights

28 Jul 17
Zynerba Pharmaceuticals Mourns Passing of Director Cynthia A. Rask

26 Jun 17
Zynerba Pharmaceuticals Added to the Russell 3000® Index

26 Jun 17
Zynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical Program

8 Jun 17
Zynerba Pharmaceuticals Achieves Target Enrollment in Exploratory Phase 2 Trial of ZYN002 in Fragile X Syndrome

1 Jun 17
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference

9 May 17
Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights

27 Mar 17
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Operational Highlights

13 Mar 17
Zynerba Pharmaceuticals to Report Fourth Quarter and Full-Year 2016 Financial and Operating Results on March 27, 2017